Prescient Therapeutics (ASX: PTX)
Live Investor Briefing
Register for an upcoming webcast
Please join Prescient Therapeutics CEO Steven Yatomi-Clarke for a special live investor briefing.
Event Details:
Register for an upcoming webcast
In the session, Steven will discuss:
- PTX’s three new next-gen CAR-T programs in hematological and solid cancers with massive addressable markets and unmet needs
- Using OmniCAR’s unique features to create therapies where current generation CAR-Ts have struggled
- Additional follow-on research programs will also demonstrate OmniCAR’s many unique features and properties and create future clinical candidates
This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.
Book Your Spot
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets have been engaged to help manage our investor communications.